Time to neutrophil engraftment
| Randomly assigned treatment group . | No. . | Cumulative incidence . | Mann-Whitney P . | |
|---|---|---|---|---|
| Median time to neutrophil engraftment (d)* . | 95% CI . | |||
| Omidubicel | 62 | 12.0 | 10.0-14.0 | <.001 |
| Control | 63 | 22.0 | 19.0-25.0 | |
| Randomly assigned treatment group . | No. . | Cumulative incidence . | Mann-Whitney P . | |
|---|---|---|---|---|
| Median time to neutrophil engraftment (d)* . | 95% CI . | |||
| Omidubicel | 62 | 12.0 | 10.0-14.0 | <.001 |
| Control | 63 | 22.0 | 19.0-25.0 | |
Patients who did not receive a transplant or who did not engraft on or before day 42 after transplantation were assigned to day 43.